Imagine a high-tech medical lab that fits inside a shipping container and can be dropped anywhere in the world. It uses satellite internet to send data instantly and can spot viruses before people even feel sick. It's like a pop-up clinic with the power of a major hospital laboratory.
Current pandemic responses are slowed by a lack of flexible, high-quality testing facilities that can be deployed quickly to remote areas. There is also a gap in detecting diseases during the asymptomatic incubation period.
A modular Rapid Response Mobile Laboratory (RRML) and a semi-autonomous biomarker discovery pipeline. They also created a data model for information exchange and a pandemic testing playbook.
If you are a medical equipment manufacturer dealing with the need for rapid deployment in crisis zones — this project developed a modular Rapid Response Mobile Laboratory (RRML) that provides point-of-need disease detection and high-level situational awareness.
If you are a satellite connectivity provider dealing with remote health data transmission — this project developed a system integrating satellite communications with laboratory information systems to enable wide-area GIS enabled monitoring.
If you are a diagnostic kit developer dealing with slow biomarker discovery — this project developed a semi-autonomous disease-specific biomarker discovery workflow to enhance testing capacity.
Based on available project data, specific pricing and cost structures are not provided.
Yes, the project focuses on modular RRMLs designed to be flexible and scalable for multi-scenario deployments across various settings.
Based on available project data, specific IP and licensing details are not mentioned.
It uses a specific data model for information storage and exchange to ensure data can be shared with response partners and stakeholders.
The project period runs from 2022-10-01 to 2025-09-30.
The consortium is highly commercially oriented with 10 industry partners (45% industry ratio), including 8 SMEs. This mix of 22 partners across 10 countries, combining 6 universities and 2 research centers, suggests a strong push toward translating the mobile lab technology into a viable commercial product.
Contact STICHTING AMSTERDAM UMC
Contact us to explore licensing the biomarker discovery workflow or RRML design.
